Work Here?
Yale New Haven Health
Work Here?
Integrated hospital system with academic affiliations
Yale New Haven Health
Work Here?
Integrated hospital system with academic affiliations
Overview
Yale New Haven Health is a health system that operates five hospitals (Yale New Haven, Bridgeport, Greenwich, Lawrence + Memorial, Westerly) and provides access to a wide network of primary care physicians and specialists through Northeast Medical Group and Yale Medicine. Through its affiliation with Yale University and Yale School of Medicine, it connects patients to the latest medical treatments and research. Its facilities and outpatient locations enable coordinated care across a single organization that aims to be more patient-focused, more accessible, and more cost-effective. The system delivers care by combining hospital services, primary and specialty care, and advanced clinical relationships to integrate treatment with ongoing research and clinical trials, offering patients access to innovative therapies and personalized treatment options.
About Yale New Haven Health
Industries
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
New Haven, Connecticut
Founded
1996
Get referred to Yale New Haven Health
See people who can refer or advise you
Simplify's Take
What believers are saying
- Wallingford's proton center opened September 1, 2026, creating a new referral magnet.
- Rad AI will roll reporting tools across 16 outpatient imaging centers and five hospitals.
- Gallion Health partnership starts August 19, 2026, targeting supply-chain savings and automation inside YNHHS.
What critics are saying
- March 2025 ransomware triggered an $18 million settlement and damaged patient trust through 2026.
- YNHHS reported a $200 million fiscal 2025 loss and cut management roles into 2026.
- Prospect acquisition litigation and DOJ scrutiny keep leadership and capital trapped until court resolution.
What makes Yale New Haven Health unique
- Yale affiliation gives YNHHS academic depth across five hospitals and specialty networks.
- Collaborations with Hartford HealthCare and Proton International launched Connecticut's first proton center September 1, 2026.
- YNHHS co-develops tools with Rad AI and Gallion, shaping workflow software around real operations.
Help us improve and share your feedback! Did you find this helpful?
Company News
Hartford HealthCare, Yale NH Health mark opening of $75M proton therapy center. September 1, 2026 More than four years after receiving final approval and less than two years after breaking ground, the state's two largest health systems held a grand opening Tuesday for Connecticut's first proton therapy center in Wallingford. The $75 million project, located at 932 Northrop Road, is a joint venture between Hartford HealthCare and Yale New Haven Health System. The grand opening was attended by state and health system officials, who praised the two health systems for collaborating on the project. "I would just simply like to say thank you to both institutions and everybody involved for the grace and the dedication and the commitment that everybody brought to the table to make this project happen," said Chris Chandler, CEO of Proton International, which collaborated on the facility. "This is unique; it's done right so that we didn't have a proton war in this state." The 25,000-square-foot Connecticut Proton Therapy Center is the state's first to use highly targeted radiological proton therapy, rather than X-rays, to treat cancer. There are approximately 50 proton therapy centers nationwide, but none in Connecticut until now. The closest centers previously were in New York and Massachusetts. A second, $96 million proton therapy center in the state has been approved to be constructed in Danbury. The two health systems announced in April 2022 that they had secured final approval to build the center and initially indicated it would open in 2025 before it was delayed by the COVID-19 pandemic. The project began construction in October 2024. HHC and YNHHS are principals of Connecticut Proton Therapy Center LLC, formed in 2019. The LLC purchased the vacant 12 acres on Northrop Road in July 2021 for $1.8 million. Chandler conceded that "proton war" was a little strong to describe competing efforts to create such a facility, but said competing health systems elsewhere have been unable to collaborate. "They did the right thing," he said of Hartford HealthCare and Yale New Haven Health. "They did the right thing for healthcare, for cost control, efficiency and for the patient, which is ultimately what we're all about." Other speakers during the event included Gov. Ned Lamont, state Comptroller Sean Scanlon, Public Health Commissioner Dr. Manisha Juthani, Hartford HealthCare President and CEO Jeff Flaks and Yale New Haven Health Interim President Pamela Sutton-Wallace. Last October, a 55-metric-ton Cyclotron - the powerful particle accelerator at the heart of the new center - was lifted from the ground by a 650-ton crane and lowered through the roof of the building, which was still under construction at the time. The Cyclotron was lowered to the building's first floor through holes specifically designed for the machine in the roof and upper floors. Proton therapy uses a high energy beam of protons to irradiate cancer. With proton beams, there is less entry, exit, and scattered radiation. That allows physicians to deliver higher doses of radiation to tumors, with less impact on healthy tissue and fewer side effects compared to other radiation therapies, the health systems said. The therapy can be used against solid cancer tumors, such as tumors of the brain, central nervous system, eye, gastrointestinal tract, head and neck, liver, lung, prostate, spine and breast.
HHC and Yale New Haven Health celebrate Connecticut Proton Center grand opening. September 01, 2026 Hartford HealthCare and Yale New Haven Health celebrated the grand opening of the Connecticut Proton Center, marking a new era in cancer care and bringing the state's first proton beam therapy center to patients. Located at 932 Northrop Road in Wallingford, the 25,000-square-foot facility will provide one of the world's most advanced forms of radiation therapy, allowing patients to receive highly targeted cancer treatment while minimizing radiation exposure to surrounding healthy tissue. The Connecticut Proton Center is the result of an unprecedented collaboration between Hartford HealthCare, Yale New Haven Health and Proton International, a global leader in proton therapy development and operations. Yale Medicine and Radiation Oncology, PC will provide clinical leadership for the center. "The Connecticut Proton Center combines the clinical expertise, scientific leadership and shared vision of our organizations to deliver an important new capability for patients throughout the region," said Pamela Sutton-Wallace, acting CEO, Yale New Haven Health. "It reinforces Connecticut's role as a leader in healthcare innovation and demonstrates our collective commitment to shaping the future of cancer care. Healthcare's greatest opportunities are realized when institutions work together to address the needs of the communities they serve." Jeffrey A. Flaks, president and CEO of Hartford HealthCare, said the opening represents a transformative moment for patients throughout Connecticut and the Northeast. "Today marks a defining milestone for cancer care in Connecticut. Through this extraordinary partnership with Yale New Haven Health and Proton International, we are expanding access to one of the world's most advanced cancer treatments, right here at home. The Connecticut Proton Center reflects what's possible when organizations come together with a shared commitment to innovation, clinical excellence and, most importantly, better outcomes for patients. Together, we are making Connecticut a destination for world-class cancer care." What the Connecticut Proton Center will offer. The Connecticut Proton Center is equipped with the latest proton beam therapy technology, delivering highly precise radiation that targets tumors while reducing unnecessary radiation exposure to nearby healthy tissue. This precision can lessen side effects, preserve quality of life and improve long-term outcomes for many patients. Proton therapy is used to treat a wide range of cancers, including tumors affecting the brain and central nervous system, eye, head and neck, gastrointestinal tract, liver, lung, prostate, spine and breast. It is especially beneficial for pediatric patients because it helps minimize radiation exposure to developing tissues. Chris Chandler, CEO of Proton International, said the center represents a significant advancement in access to life-changing cancer care. "The opening of the Connecticut Proton Center represents years of collaboration and a shared vision to bring the latest advancements in cancer treatment closer to patients. We are proud to partner with Hartford HealthCare and Yale New Haven Health to deliver world-class proton therapy that will benefit patients across Connecticut and throughout the region." The Connecticut Proton Center includes a state-of-the-art treatment room, control room, patient exam rooms and clinical space designed to deliver a seamless patient experience. The facility will be staffed by physicians and colleagues from Yale New Haven Health and Hartford HealthCare. Proton International served as the project manager and technology partner for the facility, overseeing development, construction and operational readiness. What is proton therapy? Proton therapy is an advanced form of radiation therapy that uses high-energy proton beams to precisely target cancerous tumors. Unlike conventional X-ray radiation, proton therapy allows clinicians to better control where radiation is delivered, reducing exposure to healthy organs and tissue beyond the tumor. This precision enables physicians to safely deliver higher doses of radiation directly to cancer while minimizing side effects and reducing the risk of long-term complications.
Peak XV Partners participated in Texas-based Arintra's $25 million Series B funding round, marking a follow-on investment after leading the healthcare AI startup's Series A. Define Ventures led the round, with participation from Y Combinator, Ten13 Capital, Counterpart Ventures, Spider Capital, Yale New Haven Ventures and Endeavor Ventures. Arintra, which also operates in Bengaluru, provides an autonomous medical coding platform for healthcare providers. The company uses GenAI and large language models to interpret patient charts and automate coding workflows, integrating with electronic health record systems like Epic and Athena. Peak XV has been expanding its focus on US-based AI investments since splitting from Sequoia Capital in 2023, recently backing voice AI startups Wispr Flow and Vapi.
Gallion Health announces Yale New Haven Health as development partner and investor to advance next-generation Supply Chain technology. Joint Development Partnership provides Gallion Health access to one of the country's leading academic health systems to further the development of the Company's products and service offerings. Boston, MA, August 19, 2026 -( PR.com )- Gallion Health today announced that Yale New Haven Health (YNHHS) will become a joint development partner for its bill-only platform, alongside piloting the technology across YNHHS facilities. The collaboration pairs Gallion's engineering and data science teams with YNHHS' supply chain, operations and finance leaders to co-develop new platform capabilities informed by real-world use at one of the country's leading academic health systems. Gallion's platform, first built at the University of Maryland Medical System's innovation studio, iHarbor, uses real-time validation to catch bill-only documentation errors as they happen, rather than requiring costly after-the-fact corrections. As a development partner, YNHHS will provide clinical and operational expertise to help guide Gallion's product roadmap, helping tailor future features and new products to the needs of large, multi-hospital systems. The joint development work will focus on new features, products and solutions, AI-enabled capabilities, and workflow enhancements identified during the pilot deployment. "Co-development partnerships like this one are exactly how we want to build Gallion's future. Bringing YNHHS' team directly into our product process means we're solving real problems for real health systems, not building in a vacuum, and this investment shows they're committed to that work for the long term." - Jeff Sopko, President and CEO, Gallion Health "We didn't want to be just another customer. Joining as a development partner gives our supply chain team a direct role in shaping how this technology evolves, helping ensure the platform continues to address the specific challenges we see every day." - Jacqueline Epright, Vice President and Chief Supply Chain Officer, Yale New Haven Health Gallion and YNHHS expect to share progress from the co-development effort, including new platform capabilities, over the coming year. YNHHS, one of the largest and most comprehensive healthcare systems in Connecticut, is recognized for advanced clinical care, quality, service, cost effectiveness and commitment to improving the health status of the communities it serves. YNHHS includes five hospitals - Bridgeport, Greenwich, Lawrence + Memorial, Westerly and Yale New Haven hospitals, several specialty networks and Northeast Medical Group, a non-profit medical foundation with several hundred community-based and hospital-employed physicians. YNHHS is affiliated with Yale University and Yale Medicine, the clinical practice of the Yale School of Medicine and the largest academic multi-specialty practice in New England. Yale New Haven Hospital is the primary teaching hospital of Yale School of Medicine. About Gallion Health Gallion Health is a Boston-based health care technology company delivering the industry's only end-to-end, cloud-based bill-only platform. Originally developed at the University of Maryland Medical System (UMMS), where it has been deployed across 12 hospitals, Gallion integrates with electronic health record (EHR) and enterprise resource planning (ERP) systems to automate consumption tracking, charge capture and contract compliance in real time. Gallion Health was spun out of UMMS' innovation studio, iHarbor.in 2025 and is led by President and CEO Jeff Sopko. For more information, visit www.gallionhealth.com. Gallion Health, Inc. Jeffrey S. Sopko, President and CEO 857-219-4338 www.gallionhealth.com
Connecticut Children's Medical Center caves to Trump DOJ on gender-affirming care. The settlement with the Justice Department comes as transgender patients challenge the hospital's earlier decision to cut off care under Connecticut law. A pediatric patient is inoculated by a Nurse at Hartford Healthcare's mass vaccination center at the Connecticut Convention Center in Hartford, Connecticut, on May 13, 2021. A Connecticut hospital has agreed to Trump administration demands to stop providing gender-affirming care to minors, leaving transgender youth and their families scrambling amid concerns about continuity of care. The Justice Department announced Friday that Connecticut Children's Medical Center had agreed to cease what the department calls "sex-rejecting procedures on minors," making it the third medical institution to enter into a settlement agreement with the administration. The hospital will also pay a penalty and set aside $500,000 to provide care for individuals who say they were harmed by gender-affirming care they previously received. Support Independent Journalism LGBTQ+ stories deserve to be told. Your membership powers The Advocate's original reporting - stories that inform, protect, and celebrate its community. "The Department of Justice will stop at nothing to protect America's children," said Associate Attorney General Stanley Woodward. "This resolution is a reminder to hospitals, medical providers, and pharmaceutical companies that the Justice Department will vigorously enforce federal law, especially where the lives of children are endangered." The agreement comes as Connecticut Children's is already facing legal action over its decision to halt such care. Transgender patients in December brought a lawsuit against the hospital for disrupting care in alleged violation of Connecticut state law. Attorneys with GLAD Law also filed civil rights complaints against Yale New Haven Health and Connecticut Children's Medical Center, accusing the two health systems of unlawfully cutting off gender-affirming medical care for transgender patients under 19. The hospital abruptly stopped providing care last year after President Donald Trump issued an executive order banning federal support for gender-affirming care for minors. Justice Department officials told the Hartford Courant that the institution had potentially violated the Federal Food, Drug, and Cosmetic Act and the False Claims Act by providing gender-affirming care and could have committed health care fraud. The administration has threatened institutions with the loss of federal funding, including Medicare and Medicaid payments, if they refuse to comply with its demand to cease gender-affirming care for minors. Connecticut Children's also acknowledged the settlement in a statement to the Courant. "We can confirm we have reached a resolution that allows our organization to remain focused on our mission of improving the health and well-being of children," the health system said. "Most importantly, patient privacy remained our foremost concern throughout this process and we were able to resolve this matter without disclosing any protected patient information to the US government. We have complied and will continue to comply with all federal and state laws. We have no additional comment beyond the information contained in today's DOJ announcement." 0 seconds of 1 minute, 15 seconds Volume 0%
There are no jobs for Yale New Haven Health right now.
Find jobs on Simplify and start your career today
About Yale New Haven Health
Industries
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
New Haven, Connecticut
Founded
1996
There are no jobs for Yale New Haven Health right now.
Find jobs on Simplify and start your career today